Microsystems and Nanoscience for Biomedical Applications: A View to the Future

Abstract

At present there is an enormous discrepancy between our nanotechnological capabilities (particularly our nanobiotechnologies), our social wisdom, and consensus on how to apply them. To date, cost considerations have greatly constrained our application of nanotechnologies. However, novel advances in microsystem platform technologies are about to greatly diminish that economic constraint while developing new industries. Properly used in a solid legal and ethical framework, within an educated population, these advances will vastly enrich our quality of life without being intrusive. Improperly used, these technologies could lead to a modern-day Luddism, social turmoil, or possibly even to emulating those societies described in the darkest of novels. These technologies must be developed in tandem with the social and legal frameworks needed to ensure that they improve both individuals and our society. To ensure that this occurs, we need to have the ethical, legal, scientific, and engineering experts working together and with the public.

Get full access to this article

View all access options for this article.

References

Biesecker, B., & Marteau, T. (1999). The future of genetic counseling: An international perspective . Nature Genetics, 22, 133-137 .

Buchanan, A., Brock, D., Daniels, N., & Wikler, D. (2000). From chance to choice: Genetics and justice. Cambridge, UK: Cambridge University Press .

Caulfield, T. (1999). Gene testing in the biotech century: Are physicians ready? Canadian Medical Association Journal, 161, 1122-1124 .

Caulfield, T., & Williams-Jones, B. (1999) The commercialization of genetic research: Ethical, legal and policy issues. New York: Kluwer Academic/Plenum Publishing .

Collins, F., & Guttmacher, A. (2001). Genetics moves into the medical mainstream . Journal of the American Medical Association, 286(18), 2322-2324 .

Hunter, A., Wright, P., Cappelli, M., Kasaboski, A., & Surh, L. (1998). Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients . Clinical Genetics, 53, 447-455 .

Keller, E. F. (2001). The century of the gene. Cambridge, MA: Harvard University Press .

Kristoffersson, U. (2000). The challenge of validating genetic testing . Community Genetics, 3(4), 170-174 .

Lemmens, T., & Austin, L. (2001). The challenge of regulating the use of genetic information. Retrieved April 2, 2003, from http://www.isuma.net/v02n03/index_e/shtml

10.

Mehta, M. (2002, November/December). Privacy vs. surveillance: How to avoid a nano-panoptic future. Canadian Chemical News, pp. 31-33.

11.

Morange, M. (2001). The misunderstood gene (M. Cobb, Trans.). Cambridge, MA: Harvard University Press .

12.

Nissenbaum, H. (1998). Protecting privacy in an information age: The problem of privacy in public . Law and Philosophy, 17, 559-596 .

13.

Tri-Council. (1998). Social Sciences and Humanities Research Council, Natural Sciences and Engineering Research Council, Medical Research Council. Tri-Council policy statement on ethical conduct for research involving humans. Ottawa, Canada: Public Works & Government Services Canada . Available at http://www.nserc.ca/programs/ethics/english/index.htm

14.

Vandelac, L., & Lippman, A. (1992). Questions d’éthique et d’évaluation sociale des technologies. In M. Melancon & R. Lambert (Eds.), Le Génome humain une responsabilité scientifique et sociale (pp. 83-100). Sainte-Foy, Canada: The University of Laval Press .

15.

Wertz, D. (1997). Society and the not-so-new genetics: What are we afraid of? Some future predictions from a social scientist . Journal of Contemporary Health Law & Policy, 13, 299-345 .